• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2012-2013 年威斯康星州感染风险增加人群中的丙型肝炎快速检测。

Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.

出版信息

MMWR Morb Mortal Wkly Rep. 2014 Apr 11;63(14):309-11.

PMID:24717818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5779376/
Abstract

An estimated 3.2 million persons in the United States have chronic infection with hepatitis C virus (HCV). Most new HCV transmissions occur among persons who inject drugs, often within the first few years of their injection drug use. During 2003-2012, reports of HCV infection increased from 15 to 54 cases per 100,000 among persons aged <30 years in Wisconsin, and 58% of persons in this age group with acute HCV infection reported injecting drugs (Wisconsin Division of Public Health, unpublished data, 2013). To increase detection of HCV infection, the Wisconsin Division of Public Health (WDPH) piloted a program during October 2012-October 2013 that offered rapid HCV testing to clients of four agencies providing outreach testing for HCV and human immunodeficiency virus infection, syringe exchange, counseling, and other harm reduction services to persons with drug dependence. During that period, 1,255 persons were tested using a rapid HCV test, and 246 (20%) of the results were positive. Most (72%) of the infections had not been reported to WDPH. A blood specimen for further testing was collected from 192 (78%) participants with positive HCV test results; among these participants, 183 were tested for HCV RNA using reverse transcription-polymerase chain reaction (RT-PCR), and these results were positive for 128 (70%) participants, indicating active infection. Use of the rapid HCV test detected previously unreported HCV infections and raised awareness of HCV. Persons identified with active HCV infection should be referred to medical care and counseled on ways to prevent HCV transmission to others.

摘要

据估计,美国有 320 万人患有慢性丙型肝炎病毒(HCV)感染。大多数新的 HCV 传播发生在注射毒品的人群中,通常是在他们开始注射毒品的最初几年内。在 2003 年至 2012 年期间,威斯康星州报告的 HCV 感染病例从每 10 万人中有 15 例增加到 54 例,年龄在 30 岁以下的人群中,有 58%的急性 HCV 感染患者报告注射毒品(威斯康星州公共卫生部,未发表的数据,2013 年)。为了增加 HCV 感染的检测,威斯康星州公共卫生部(WDPH)在 2012 年 10 月至 2013 年 10 月期间试行一项计划,为四家机构的客户提供快速 HCV 检测,这些机构为 HCV 和人类免疫缺陷病毒感染、注射器交换、咨询和其他减少药物依赖者伤害的服务提供外展检测。在此期间,有 1255 人使用快速 HCV 检测进行了检测,其中 246 人(20%)的检测结果为阳性。大多数(72%)感染病例未向 WDPH 报告。从 192 名 HCV 检测阳性结果的参与者中采集了进一步检测的血液样本;在这些参与者中,有 183 人使用逆转录聚合酶链反应(RT-PCR)检测 HCV RNA,其中 128 人(70%)的结果为阳性,表明存在活动性感染。快速 HCV 检测的使用发现了以前未报告的 HCV 感染,并提高了对 HCV 的认识。应将确诊患有活动性 HCV 感染的人转介到医疗保健机构,并就如何防止 HCV 传播给他人进行咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aca/5779376/de1b663fc8fc/309-311f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aca/5779376/de1b663fc8fc/309-311f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aca/5779376/de1b663fc8fc/309-311f1.jpg

相似文献

1
Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.2012-2013 年威斯康星州感染风险增加人群中的丙型肝炎快速检测。
MMWR Morb Mortal Wkly Rep. 2014 Apr 11;63(14):309-11.
2
Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.宾夕法尼亚州费城五家健康中心丙型肝炎病毒感染者的识别与护理关联——2012 - 2014年
MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):459-63.
3
Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.生命体征:丙型肝炎病毒感染检测和报告的评估- 2005-2011 年美国八个地点。
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.
4
Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.4 个国家级人类免疫缺陷病毒行为监测系统点的丙型肝炎病毒抗体快速检测试剂的性能。
Clin Infect Dis. 2011 Oct;53(8):780-6. doi: 10.1093/cid/cir499.
5
Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.评估一种新的、快速的检测 HCV 感染的方法,适用于血液或口腔液样本。
J Virol Methods. 2011 Mar;172(1-2):27-31. doi: 10.1016/j.jviromet.2010.12.009. Epub 2010 Dec 21.
6
Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.在血清转化前长时间抗体检测不到的时期,注射吸毒者的血清、血浆和外周血单核细胞中丙型肝炎病毒RNA水平较低。
Blood. 1999 Aug 15;94(4):1183-91.
7
Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.肯尼亚注射毒品者利用减少伤害服务的丙型肝炎病毒流行率、估计发病率、风险行为和基因型分布:一项回顾性队列研究。
Lancet Infect Dis. 2019 Nov;19(11):1255-1263. doi: 10.1016/S1473-3099(19)30264-6. Epub 2019 Sep 17.
8
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.澳大利亚市中心急诊部门即时检测丙型肝炎病毒和与治疗的衔接
Int J Drug Policy. 2019 Oct;72:84-90. doi: 10.1016/j.drugpo.2019.06.021. Epub 2019 Jul 24.
9
Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.爱尔兰针对输血受者的一项选择性丙型肝炎病毒筛查项目的结果。
Transfusion. 2002 Nov;42(11):1501-6. doi: 10.1046/j.1537-2995.2002.00224.x.
10
The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.聚合酶链反应检测法对血液透析单位丙型肝炎病毒感染检测的影响
Saudi J Kidney Dis Transpl. 2007 Mar;18(1):107-13.

引用本文的文献

1
Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.大城市监狱中的丙型肝炎流行病学:人口统计学的变化。
Public Health Rep. 2023 Mar-Apr;138(2):248-258. doi: 10.1177/00333549221076546. Epub 2022 Mar 3.
2
Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection.甲型肝炎和乙型肝炎疫苗接种覆盖率在注射毒品且有丙型肝炎感染证据的人群中。
Public Health Rep. 2019 Nov/Dec;134(6):651-659. doi: 10.1177/0033354919874088. Epub 2019 Sep 20.
3
Identifying barriers to treatment of HCV in the primary care setting.

本文引用的文献

1
Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention.在年轻的注射吸毒者中使用注射毒品和丙型肝炎病毒感染:利用证据告知全面预防。
Clin Infect Dis. 2013 Aug;57 Suppl 2(Suppl 2):S32-8. doi: 10.1093/cid/cit300.
2
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.成人丙型肝炎病毒感染筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2013 Sep 3;159(5):349-57. doi: 10.7326/0003-4819-159-5-201309030-00672.
3
Testing for HCV infection: an update of guidance for clinicians and laboratorians.
确定初级保健环境中 HCV 治疗的障碍。
Hepatol Int. 2019 Jan;13(1):58-65. doi: 10.1007/s12072-018-9902-x. Epub 2018 Oct 30.
4
Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.在人类免疫缺陷病毒合并感染人群中消除丙型肝炎病毒:利用现有的人类免疫缺陷病毒基础设施。
Infect Dis Clin North Am. 2018 Jun;32(2):407-423. doi: 10.1016/j.idc.2018.02.005.
5
Hepatitis B and C.乙型和丙型肝炎
Pediatr Clin North Am. 2017 Jun;64(3):641-658. doi: 10.1016/j.pcl.2017.01.007.
6
Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs.在注射毒品者和使用 syringe-exchange 项目的人群中,快速即时检测丙型肝炎的可接受性。
Open Forum Infect Dis. 2016 Apr 6;3(2):ofw075. doi: 10.1093/ofid/ofw075. eCollection 2016 Mar.
7
Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage.即时人免疫缺陷病毒-乙型肝炎-丙型肝炎检测在关联治疗中的改善效果:一项在无医疗保健覆盖人群中进行的随机对照试验结果。
Open Forum Infect Dis. 2015 Oct 26;2(4):ofv162. doi: 10.1093/ofid/ofv162. eCollection 2015 Dec.
8
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.基于证据的干预措施,以加强慢性丙型肝炎护理连续过程中的评估、治疗和依从性。
Int J Drug Policy. 2015 Oct;26(10):922-35. doi: 10.1016/j.drugpo.2015.05.002. Epub 2015 May 17.
9
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014.法国未被诊断出的慢性丙型肝炎病毒感染人群。对2014年扩大检测建议的影响。
PLoS One. 2015 May 11;10(5):e0126920. doi: 10.1371/journal.pone.0126920. eCollection 2015.
10
A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.罗德岛惩教部丙型肝炎病毒快速检测的一项试点研究。
J Public Health (Oxf). 2016 Mar;38(1):130-7. doi: 10.1093/pubmed/fdv023. Epub 2015 Mar 2.
丙型肝炎病毒感染检测:临床医生和实验室人员指南更新。
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):362-5.
4
Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis.快速即时检测丙型肝炎病毒的准确性:系统评价和荟萃分析。
Ann Intern Med. 2012 Oct 16;157(8):558-66. doi: 10.7326/0003-4819-157-8-201210160-00006.
5
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.系统评价和荟萃分析干预措施预防注射吸毒人群感染丙型肝炎病毒。
J Infect Dis. 2011 Jul 1;204(1):74-83. doi: 10.1093/infdis/jir196.
6
Surveillance for acute viral hepatitis - United States, 2007.2007年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2009 May 22;58(3):1-27.
7
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.1994 - 2004年美国注射吸毒者中丙型肝炎病毒感染的患病率。
Clin Infect Dis. 2008 Jun 15;46(12):1852-8. doi: 10.1086/588297.
8
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.1999年至2002年美国丙型肝炎病毒感染的流行情况。
Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004.
9
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.丙型肝炎病毒(HCV)感染及HCV相关慢性病的预防与控制建议。疾病控制与预防中心。
MMWR Recomm Rep. 1998 Oct 16;47(RR-19):1-39.
10
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.短期注射吸毒者中的病毒感染:丙型肝炎病毒、乙型肝炎病毒、人类免疫缺陷病毒和人类嗜T淋巴细胞病毒的流行情况
Am J Public Health. 1996 May;86(5):655-61. doi: 10.2105/ajph.86.5.655.